financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Adss Of Wipro Limited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Adss Of Wipro Limited
Apr 22, 2024 3:04 AM

05:40 AM EDT, 04/22/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We adjust our target price to USD6.00 (from USD5.50), valuing Wipro ( WIT ) on a higher 22x FY 25 (Mar.) P/E (from 19x), slightly above its 5-year mean P/E to reflect our expectation of a decent EPS growth pickup through FY 26. Notably, we forecast EPS +7% to INR22.25 (trimmed from INR24.16) in FY 25 and +11% to INR24.66 in FY 26. Wipro's ( WIT ) FY 24 result came in slightly below our expectations, with flat EPS at INR20.82 on -1% revenue to INR898 mln. FY 24 EBIT margin were mostly unchanged (-0.1%-pts to 14.9%) as the impact of salary hikes in November 2023 was mostly offset by improving mix of high-value transformation projects. Wipro ( WIT ) reported 25% increase in FY 24 total deal wins by TCV (FY 23: +20%), but we highlight that deal conversions will be challenging amid a weak discretionary IT spending environment. Overall, we stay neutral on the stock given its unexciting earnings growth outlook, although we highlight potential shareholder returns from Wipro's ( WIT ) net cash, currently equivalent to 21% of assets.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Jun 11, 2024
03:25 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $990 from $940, reflecting a 51.7x multiple on our 2025 EPS estimate, above LLY's historical forward P/E average. We maintain our 2024 EPS estimate at...
Understanding Section 7702 plans
Understanding Section 7702 plans
Jun 11, 2024
Key takeaways Section 7702 of the IRS tax code outlines the criteria that life insurance policies must meet to qualify for tax advantages. The term '7702 plan' is a loose marketing term, not a specific type of life insurance policy. It typically refers to the tax treatment of cash value life insurance policies, which can include whole, universal, variable...
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Jun 11, 2024
01:05 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We set our 12-month target at $65, representing an estimated 2025 P/E of 43.3x. We initiate coverage at Hold, as we see adj-EPS growth to $1.10 in 2024 and $1.50...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024
11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount...
Copyright 2023-2026 - www.financetom.com All Rights Reserved